The Welsh minister for health has rejected calls for a takeover of Betsi Cadwaladr University Health Board (BCUHB) by a health board from elsewhere in the UK, saying devolved legislation and accountability to the Senedd mean the board must remain under Welsh control. The decision comes as the minister announced the formation of a "well-led" expert panel intended to steer the health board out of special measures.
Minister refuses external health board takeover
Addressing the Senedd, the minister said he would "not even countenance" allowing a health board from outside Wales to run BCUHB, arguing that such boards operate under different rules and that the health service in Wales is governed by its own legislative framework. The minister told members the health board answers to the Senedd and to the people of Wales.
"No, I will not even countenance the idea of allowing a health board from outside of Wales to take over Betsi Cadwaladr, because they work to different rules and regulations."
That position was challenged by Reform Wales representatives in the chamber, who said local patients have suffered from prolonged waits and what they characterised as failures in leadership and governance. Adrian Mason MS urged the Welsh government to seek "the very best clinical, operational and turnaround expertise" from across the UK to accelerate improvement.
Expert panel and demands for transparency
The minister announced an intensive support, recovery and turnaround team alongside plans for a well-led review to be conducted by a panel of health experts. One name reported to be under consideration for the panel is NHS troubleshooter Donna Ockenden.
Opposition members have pressed the minister to publish key details about the initiative, specifically requesting:
- membership of the expert panel;
- the panel's terms of reference;
- clear monthly performance targets and contingency actions if targets are missed.
Reform Wales' shadow counsel general argued that devolution should not become an excuse for insularity and said patients "will not care where that expertise comes from – they care whether it saves lives and improves treatment." He warned against a "constitutional bidding war" and said accountability should remain with the Welsh government while external expertise is used to deliver improvements.
What is at stake
BCUHB, which has been under special measures, provides health services to a large population in north Wales. The disagreement in the Senedd highlights a tension that can arise in devolved systems between maintaining local control and bringing in external operational capacity to resolve entrenched problems. Ministers stress local accountability; critics stress speed and effectiveness of improvement.
Calls for the publication of the panel's membership and remit reflect concerns about both transparency and independence. Without published terms of reference it will be difficult for clinicians, staff and the public to judge whether the review is sufficiently robust, time-limited and empowered to effect change.
| Issue | Minister's position | Opposition demand |
|---|---|---|
| External takeover by another health board | Rejected — not compatible with Welsh rules | Should be considered to bring in turnaround expertise |
| Expert panel | Announced — well-led review and turnaround team | Publish membership, terms of reference and targets |
| Accountability | Remains with Senedd and Welsh government | Use best UK expertise while retaining Welsh accountability |
Public confidence in and the performance of the health board are central to the debate. Critics point to long waits and unacceptable performance as justification for swift, external intervention; ministers and proponents of Welsh-only oversight underline the importance of respecting devolved regulatory frameworks and local democratic accountability.
Next steps and uncertainties
The minister has indicated the review and recovery team will proceed, but has not yet published full details of the expert panel's membership or the terms under which it will operate. Opposition calls for monthly performance targets and explicit contingency plans remain unanswered in public detail.
The effectiveness of the announced measures will depend on the composition and remit of the expert panel, the clarity of improvement targets, and the mechanisms by which the Welsh government will monitor progress without sacrificing accountability. Until those details are published, it will be difficult to assess whether the approach offers a credible alternative to the external takeover proposed by some critics.
As the situation develops, transparency about the panel's work and measurable milestones will be central to rebuilding confidence among patients, staff and elected representatives.
